Although these in vitro studies are highly encouraging, combining such drugs with Th1-polarizing vaccination has potential limitations that must be considered, since many of the signaling pathways in cancer cells potentially suppressed by inhibitors of receptor tyrosine kinases are also critical in immune system cells. Here, NTRK1 is linked to cancer.